Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and Carboplatin
Platinum-based chemotherapy often fails due to its severe adverse effects. The aim of this study was to examine the adverse effects profile and efficacy of dicycloplatin and compare them to those of cisplatin and carboplatin. Cystoscopy surveillance of the first American cancer patient treated with...
Saved in:
Published in | Anticancer research Vol. 39; no. 8; pp. 4455 - 4462 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
International Institute of Anticancer Research
01.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!